Sunday, March 03, 2024
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



WHO, MPP announce first global license for Covid-19 technology

Geneva, Nov 23 (Prensa Latina) WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) on Tuesday finalized a licensing agreement with the Spanish National Research Council (CSIC) for a Covid-19 serological antibody technology.

The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to a Covid-19 infection or to a vaccine will be royalty-free for low- and middle-income nations and will remain valid until the date the last patent expires.

Based on an agreement reached with the Spanish national Research Council (CSIC), the license is aimed at facilitating the rapid manufacture and commercialization of CSIC´s Covid-19 serological test worldwide.

I thank CSIC and Spanish Government, for taking a step forward in solidarity and prioritizing health as a global public good and for offering worldwide access to their technology and know-how, said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

I urge developers of COVID-19 vaccines, treatments and diagnostics to follow this example and turn the tide on the pandemic and on the devastating global inequity this pandemic has spotlighted.”

Dr. Rosa Menéndez, president of CSIC, emphasized how important it is to seek solutions so that technologies related to the COVID-19 pandemic in particular, and health in general, reach all countries, including those most in need.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.